Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.

The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.

Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.

Scope of the Report:

This report focuses on the Cancer Drug Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Cancer Drug Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Amgen / Allergan

Argos Therapeutics

AstraZeneca

Aveo Pharmaceuticals

Bayer

Exelixis

Incyte

Merck

Roche

Bristol-Myers Squibb

Eisai

Exelixis

Genentech (Roche)

Novartis

Pfizer

Prometheus Labs

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Targeted Therapy

Chemotherapy

Immunotherapy

Market Segment by Applications, can be divided into

Angiogenesis Inhibitors

mTOR Inhibitors

Monoclonal Antibodies

Cytokine Immunotherapy (IL-2)

There are 15 Chapters to deeply display the global Cancer Drug Therapy market.

Chapter 1, to describe Cancer Drug Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer Drug Therapy, with sales, revenue, and price of Cancer Drug Therapy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Drug Therapy, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cancer Drug Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cancer Drug Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Cancer Drug Therapy Introduction

1.2 Market Analysis by Type

1.2.1 Targeted Therapy

1.2.2 Chemotherapy

1.2.3 Immunotherapy

1.3 Market Analysis by Applications

1.3.1 Angiogenesis Inhibitors

1.3.2 mTOR Inhibitors

1.3.3 Monoclonal Antibodies

1.3.4 Cytokine Immunotherapy (IL-2)

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen / Allergan

2.1.1 Business Overview

2.1.2 Cancer Drug Therapy Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Argos Therapeutics

2.2.1 Business Overview

2.2.2 Cancer Drug Therapy Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Argos Therapeutics Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 AstraZeneca

2.3.1 Business Overview

2.3.2 Cancer Drug Therapy Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AstraZeneca Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Aveo Pharmaceuticals

2.4.1 Business Overview

2.4.2 Cancer Drug Therapy Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Bayer

2.5.1 Business Overview

2.5.2 Cancer Drug Therapy Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Bayer Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Exelixis

2.6.1 Business Overview

2.6.2 Cancer Drug Therapy Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Exelixis Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Incyte

2.7.1 Business Overview

2.7.2 Cancer Drug Therapy Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Incyte Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Merck

2.8.1 Business Overview

2.8.2 Cancer Drug Therapy Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Merck Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Roche

2.9.1 Business Overview

2.9.2 Cancer Drug Therapy Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Roche Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Bristol-Myers Squibb

2.10.1 Business Overview

2.10.2 Cancer Drug Therapy Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Eisai

2.11.1 Business Overview

2.11.2 Cancer Drug Therapy Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Eisai Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Exelixis

2.12.1 Business Overview

2.12.2 Cancer Drug Therapy Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Exelixis Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Genentech (Roche)

2.13.1 Business Overview

2.13.2 Cancer Drug Therapy Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Genentech (Roche) Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 Novartis

2.14.1 Business Overview

2.14.2 Cancer Drug Therapy Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Novartis Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Pfizer

2.15.1 Business Overview

2.15.2 Cancer Drug Therapy Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Pfizer Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Prometheus Labs

2.16.1 Business Overview

2.16.2 Cancer Drug Therapy Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Prometheus Labs Cancer Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cancer Drug Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Cancer Drug Therapy Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Cancer Drug Therapy Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Cancer Drug Therapy Manufacturer Market Share in 2017

3.3.2 Top 6 Cancer Drug Therapy Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Cancer Drug Therapy Market Analysis by Regions

4.1 Global Cancer Drug Therapy Sales, Revenue and Market Share by Regions

4.1.1 Global Cancer Drug Therapy Sales and Market Share by Regions (2013-2018)

4.1.2 Global Cancer Drug Therapy Revenue and Market Share by Regions (2013-2018)

4.2 North America Cancer Drug Therapy Sales and Growth Rate (2013-2018)

4.3 Europe Cancer Drug Therapy Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Cancer Drug Therapy Sales and Growth Rate (2013-2018)

4.5 South America Cancer Drug Therapy Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Cancer Drug Therapy Sales and Growth Rate (2013-2018)

5 North America Cancer Drug Therapy by Countries

5.1 North America Cancer Drug Therapy Sales, Revenue and Market Share by Countries

5.1.1 North America Cancer Drug Therapy Sales and Market Share by Countries (2013-2018)

5.1.2 North America Cancer Drug Therapy Revenue and Market Share by Countries (2013-2018)

5.2 United States Cancer Drug Therapy Sales and Growth Rate (2013-2018)

5.3 Canada Cancer Drug Therapy Sales and Growth Rate (2013-2018)

5.4 Mexico Cancer Drug Therapy Sales and Growth Rate (2013-2018)

6 Europe Cancer Drug Therapy by Countries

6.1 Europe Cancer Drug Therapy Sales, Revenue and Market Share by Countries

6.1.1 Europe Cancer Drug Therapy Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Cancer Drug Therapy Revenue and Market Share by Countries (2013-2018)

6.2 Germany Cancer Drug Therapy Sales and Growth Rate (2013-2018)

6.3 UK Cancer Drug Therapy Sales and Growth Rate (2013-2018)

6.4 France Cancer Drug Therapy Sales and Growth Rate (2013-2018)

6.5 Russia Cancer Drug Therapy Sales and Growth Rate (2013-2018)

6.6 Italy Cancer Drug Therapy Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cancer Drug Therapy by Countries

7.1 Asia-Pacific Cancer Drug Therapy Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Cancer Drug Therapy Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Cancer Drug Therapy Revenue and Market Share by Countries (2013-2018)

7.2 China Cancer Drug Therapy Sales and Growth Rate (2013-2018)

7.3 Japan Cancer Drug Therapy Sales and Growth Rate (2013-2018)

7.4 Korea Cancer Drug Therapy Sales and Growth Rate (2013-2018)

7.5 India Cancer Drug Therapy Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Cancer Drug Therapy Sales and Growth Rate (2013-2018)

8 South America Cancer Drug Therapy by Countries

8.1 South America Cancer Drug Therapy Sales, Revenue and Market Share by Countries

8.1.1 South America Cancer Drug Therapy Sales and Market Share by Countries (2013-2018)

8.1.2 South America Cancer Drug Therapy Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Cancer Drug Therapy Sales and Growth Rate (2013-2018)

8.3 Argentina Cancer Drug Therapy Sales and Growth Rate (2013-2018)

8.4 Colombia Cancer Drug Therapy Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cancer Drug Therapy by Countries

9.1 Middle East and Africa Cancer Drug Therapy Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Cancer Drug Therapy Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Cancer Drug Therapy Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Cancer Drug Therapy Sales and Growth Rate (2013-2018)

9.3 UAE Cancer Drug Therapy Sales and Growth Rate (2013-2018)

9.4 Egypt Cancer Drug Therapy Sales and Growth Rate (2013-2018)

9.5 Nigeria Cancer Drug Therapy Sales and Growth Rate (2013-2018)

9.6 South Africa Cancer Drug Therapy Sales and Growth Rate (2013-2018)

10 Global Cancer Drug Therapy Market Segment by Type

10.1 Global Cancer Drug Therapy Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Cancer Drug Therapy Sales and Market Share by Type (2013-2018)

10.1.2 Global Cancer Drug Therapy Revenue and Market Share by Type (2013-2018)

10.2 Targeted Therapy Sales Growth and Price

10.2.1 Global Targeted Therapy Sales Growth (2013-2018)

10.2.2 Global Targeted Therapy Price (2013-2018)

10.3 Chemotherapy Sales Growth and Price

10.3.1 Global Chemotherapy Sales Growth (2013-2018)

10.3.2 Global Chemotherapy Price (2013-2018)

10.4 Immunotherapy Sales Growth and Price

10.4.1 Global Immunotherapy Sales Growth (2013-2018)

10.4.2 Global Immunotherapy Price (2013-2018)

11 Global Cancer Drug Therapy Market Segment by Application

11.1 Global Cancer Drug Therapy Sales Market Share by Application (2013-2018)

11.2 Angiogenesis Inhibitors Sales Growth (2013-2018)

11.3 mTOR Inhibitors Sales Growth (2013-2018)

11.4 Monoclonal Antibodies Sales Growth (2013-2018)

11.5 Cytokine Immunotherapy (IL-2) Sales Growth (2013-2018)

12 Cancer Drug Therapy Market Forecast (2018-2023)

12.1 Global Cancer Drug Therapy Sales, Revenue and Growth Rate (2018-2023)

12.2 Cancer Drug Therapy Market Forecast by Regions (2018-2023)

12.2.1 North America Cancer Drug Therapy Market Forecast (2018-2023)

12.2.2 Europe Cancer Drug Therapy Market Forecast (2018-2023)

12.2.3 Asia-Pacific Cancer Drug Therapy Market Forecast (2018-2023)

12.2.4 South America Cancer Drug Therapy Market Forecast (2018-2023)

12.2.5 Middle East and Africa Cancer Drug Therapy Market Forecast (2018-2023)

12.3 Cancer Drug Therapy Market Forecast by Type (2018-2023)

12.3.1 Global Cancer Drug Therapy Sales Forecast by Type (2018-2023)

12.3.2 Global Cancer Drug Therapy Market Share Forecast by Type (2018-2023)

12.4 Cancer Drug Therapy Market Forecast by Application (2018-2023)

12.4.1 Global Cancer Drug Therapy Sales Forecast by Application (2018-2023)

12.4.2 Global Cancer Drug Therapy Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Cancer Drug Therapy Picture

Table Product Specifications of Cancer Drug Therapy

Figure Global Sales Market Share of Cancer Drug Therapy by Types in 2017